TSHA
Taysha Gene Therapies, Inc.
1.77
USD
This page is just a preview of the data found in TrendSpider’s full version
Taysha Gene Therapies, Inc. stock is down -24.36% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 4 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 26 Oct 19:24 | 17 Nov, 2023 | 2.50 | 93 | ||
| 26 Oct 19:24 | 17 Nov, 2023 | 2.50 | 93 | ||
| 26 Oct 19:26 | 17 Nov, 2023 | 2.50 | 93 | ||
| 02 Nov 14:50 | 17 Nov, 2023 | 2.50 | 5096 |
Taysha Gene Therapies, Inc. focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company was incorporated in 2019 and is based in Dallas, Texas.
